
| Duration | Percentage |
|---|---|
| 1 week | 0.86 |
| 1 month | 4.53 |
| 6 months | 38.47 |
| 9 months | 68.40 |
| 1 year | 64.83 |
| Essentials | |
|---|---|
| Fund category | Equity - Sector Fund |
| Scheme plan | Dividend |
| Scheme type | Open Ended |
| Launch date | May 27, 1999 |
| Fund manager | Mr. Anoop Bhaskar |
| Fund info | |
|---|---|
| AMC | UTI Asset Management Co. Ltd. |
| Objective | Aim to invest in companies engaged in the research, manufacture or marketing of OTC products, bulk drugs and formulations |
| Asset (Rs crore) | 55.30 ( August 31, 2009) |
| Dividend (%) | 15.00 ( August 26, 2008) |
| Company | Percentage |
|---|---|
| Sun Pharma. | 15.68 |
| GlaxoSmithKline Phar | 10.12 |
| Dr. Reddy's Labs | 9.48 |
| Cipla | 9.06 |
| Divi's Lab | 8.04 |
| Cadila Healthcar | 7.72 |
| Lupin Ltd. | 6.65 |
| Aventis Pharma Ltd. | 5.83 |
| Ranbaxy Labs. | 4.33 |
| Piramal Healthcare L | 3.42 |
| Company | Percentage |
|---|---|
| Pharmaceuticals | 95.0 |
| Finance - Banks - Public Sector | 0.0 |
| Vanaspati | 0.0 |